Bank Of New York Mellon Corp Red Hill Biopharma Ltd. Transaction History

Bank Of New York Mellon Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.63 - $2.58 $6,300 - $25,800	-10,000 Reduced 50.0%	10,000 $9,000
Q4 2021 Feb 11, 2022	SELL	$2.31 - $5.85 $4,620 - $11,700	-2,000 Reduced 9.09%	20,000 $52,000
Q1 2021 May 13, 2021	SELL	$6.98 - $11.29 $2,477 - $4,007	-355 Reduced 1.59%	22,000 $161,000
Q3 2020 Nov 12, 2020	SELL	$6.34 - $10.83 $135,961 - $232,249	-21,445 Reduced 48.96%	22,355 $228,000
Q2 2020 Aug 12, 2020	BUY	$4.6 - $8.6 $45,075 - $84,271	9,799 Added 28.82%	43,800 $293,000
Q1 2020 May 06, 2020	BUY	$3.51 - $6.17 $3 - $6	1 Added 0.0%	34,001 $154,000
Q4 2019 Feb 14, 2020	BUY	$5.76 - $7.35 $97,920 - $124,950	17,000 Added 100.0%	34,000 $206,000
Q1 2019 May 14, 2019	BUY	$6.06 - $9.0 $30,299 - $45,000	5,000 Added 41.67%	17,000 $141,000
Q3 2018 Nov 09, 2018	SELL	$6.0 - $11.35 $6 - $11	-1 Reduced 0.01%	12,000 $0
Q1 2018 May 15, 2018	BUY	$4.96 - $6.84 $4 - $6	1 Added 0.01%	12,001 $62,000
Q4 2017 Feb 09, 2018	BUY	$4.58 - $10.81 $54,960 - $129,720	12,000	12,000 $62,000

40.4K

Ticker RDHL
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 63,823,500
Market Cap $465M
Description
RedHill Biopharma Ltd., a specialty biopharmaceutical company, primarily focuses on gastrointestinal and infectious diseases. The company promotes gastrointestinal drugs, including Movantik for opioid-induced constipation in adults with chronic non-cancer pain; Talicia for the treatment of Helicobacter pylori infection in adults; and Aemcolo for...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.